Technical analysis of Quoin Pharmaceuticals, Ltd. (QNRX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment.
Price Performance
| 1 month | +36.02% |
| 3 months | +45.38% |
| Year-to-date | -53.15% |
| 1 year | -21.30% |
| 3 years | -96.37% |
| 5 years | -100.00% |
52-Week Range
| 52-week High | $41.80 |
| 52-week Low | $3.25 |
| Avg Volume (90d) | 540K |
Technical Indicators
| SMA 50 | $5.27 |
| SMA 200 | $7.51 |
| 30-day Volatility (annualised) | 108.7% |
| Price vs SMA 50 | +28.2% |
| Price vs SMA 200 | -10.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $11.30 | |
| 2025-11 | $21.75 | +92.5% |
| 2025-12 | $14.43 | -33.7% |
| 2026-01 | $7.22 | -50.0% |
| 2026-02 | $8.37 | +15.9% |
| 2026-03 | $6.60 | -21.1% |
| 2026-04 | $6.48 | -1.8% |
| 2026-05 | $5.06 | -21.9% |
| 2026-06 | $4.84 | -4.3% |
| 2026-07 | $4.45 | -8.1% |
| 2026-08 | $6.22 | +39.8% |
| 2026-09 | $6.76 | +8.7% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | $0.05 | $88M |
| 2026-09-15 | | |
| 2026-09-15 | $0.14 | $2.28B |
| 2026-09-15 | | |
Price
| Price | $6.90 |
| Market Cap | $14M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 3.52 |
| EV / EBITDA | -0.57 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 1.76 |